Khandalekar D D, Ganu U K, Gokhale S V
Cancer Research Institute, Tata Memorial Centre, Parel, Bombay.
Indian J Physiol Pharmacol. 1989 Jul-Sep;33(3):171-4.
Studies were carried out on the combination of Cimetidine (CMTD) with Cytoxan (CTX) in three murine tumors. While the combination significantly potentiated the anticancer effect of CTX in L1210 leukemia, the results with P388 leukemia were not significantly different. The results with Lewis Lung Carcinoma showed a consistent reduction in the number of metastases. However, there was no consistent concomitant prolongation in survival. The host strain, biology of the tumour and the drug used in combination with CMTD might be some of the factors responsible for the varied response.
对西咪替丁(CMTD)与环磷酰胺(CTX)联合用于三种小鼠肿瘤进行了研究。虽然该联合用药显著增强了CTX对L1210白血病的抗癌效果,但对P388白血病的结果并无显著差异。Lewis肺癌的研究结果显示转移灶数量持续减少。然而,生存期并没有一致的相应延长。宿主品系、肿瘤生物学特性以及与CMTD联合使用的药物可能是导致不同反应的部分因素。